eureKING Logo

eureKING

KINGS | PA

Overview

Corporate Details

ISIN(s):
FR0014009ON9
LEI:
96950078TLFWTM2QE234
Country:
France
Address:
128 RUE LA BOETIE, 75008 PARIS
Sector:
Financials
Industry:
Financial Services

Description

Founded in March 2022, eureKING is a French SPAC (Special Purpose Acquisition Company) formed with the aim of acquiring European companies in the field of biomanufacturing, with the ambition of creating a leading bio-CDMO in Europe capable of meeting the growing outsourcing needs of this industry. eureKING has chosen to focus on three highly specialized and strategic segments of the biopharmaceutical industry: the production of biologics, in particular new generations of monoclonal antibodies or complex proteins, the production of cell and gene therapies and the production of live biotherapeutics (with applications in the microbiome). Led by an international management team of experienced healthcare industry talent, 100% dedicated to the eureKING project and its development strategy and supported by a Board of Directors with complementary skills in the pharmaceutical and financial fields, eureKING aims at developing and promoting the promising biomanufacturing sector in Europe.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-11-28 20:03
Inside Information Statement
Early dissolution, leading to liquidation of eureKING, approved by the sharehol…
English 314.0 KB
2023-11-28 20:03
Inside Information Statement
Dissolution anticipée, entrainant la liquidation d’eureKING, approuvée par l’as…
French 289.1 KB
2023-11-24 17:50
Inside Information Statement
Delisting of all financial instruments issued by the Company following the extr…
English 254.8 KB
2023-11-24 17:50
Inside Information Statement
Radiation de la cote de l’ensemble des instruments financiers émis par la Socié…
French 256.1 KB
2023-11-06 21:14
General Meeting Notice
Availability of the preparatory documents for the shareholders’ Extraordinary G…
English 219.2 KB
2023-11-06 21:14
General Meeting Notice
Mise à disposition des documents préparatoires à l’assemblée générale extraordi…
French 194.7 KB
2023-10-12 18:56
Inside Information Statement
eureKING will not complete its Proposed acquisitions of Skyepharma and SCTbio a…
English 205.4 KB
2023-10-12 18:56
Regulatory News Service
eureKING annonce l’abandon de son projet d’acquisition de Skyepharma et de SCTb…
French 198.7 KB
2023-10-11 16:08
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 200.3 KB
2023-10-11 16:08
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 200.6 KB
2023-10-11 16:07
Major Shareholding Notification
Franchissement de seuils et déclaration d'intention
French 353.6 KB
2023-10-09 07:35
Regulatory News Service
Update on the Proposed IBC with Skyepharma and the Proposed Acquisition of SCTb…
English 266.4 KB
2023-10-09 07:35
Regulatory News Service
Mise à jour sur l’IBC Proposé avec Skyepharma et l’Acquisition Proposée de SCTb…
French 254.4 KB
2023-10-04 08:48
Major Shareholding Notification
Franchissement de seuils
French 198.0 KB
2023-10-03 11:00
Major Shareholding Notification
Franchissement de seuils
French 264.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies